Literature DB >> 19627519

Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites.

S Kapila1, Y Xie, W Wang.   

Abstract

OBJECTIVES - Relaxin induces the matrix metalloproteinase MMP-1 (collagenase-1) in TMJ fibrocartilaginous cells, and this response is potentiated by beta-estradiol. We identified the MMP-1 promoter sites and transcription factors that are induced by relaxin with or without beta-estradiol in fibrocartilaginous cells. MATERIAL AND METHODS - Early passage cells were transiently transfected with the pBLCAT2 plasmid containing specific segments of the human MMP-1 promoter regulating the chloramphenicol acyl transferase (CAT) gene and co-transfected with a plasmid containing the beta-galactosidase gene. The cells were cultured in serum-free medium alone or medium containing 0.1 ng/ml relaxin, or 20 ng/ml beta-estradiol or both hormones, and lysates assayed for CAT and beta-galactosidase activity. RESULTS - Cells transfected with the -1200/-42 or -139/-42 bp MMP-1 promoter-reporter constructs showed 1.5-fold and 3-fold induction of CAT by relaxin in the absence or presence of beta-estradiol, respectively. Relaxin failed to induce CAT in the absence of the -137/-69 region of the MMP-1 promoter, which contains the AP-1-and PEA3-binding sites. Using wild type or mutated minimal AP-1 and PEA-3 promoters we found that both these promoter sites are essential for the induction of MMP-1 by relaxin. The mRNAs for transcription factors c-fos and c-jun, which together form the AP-1 heterodimer, and Ets-1 that modulates the PEA-3 site, were upregulated by relaxin or beta-estradiol plus relaxin. CONCLUSION - These studies show that both the AP-1 and PEA-3 promoter sites are necessary for the induction of MMP-1 by relaxin in fibrocartilaginous cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627519      PMCID: PMC2753518          DOI: 10.1111/j.1601-6343.2009.01451.x

Source DB:  PubMed          Journal:  Orthod Craniofac Res        ISSN: 1601-6335            Impact factor:   1.826


  33 in total

Review 1.  Estrogen receptor pathways to AP-1.

Authors:  P J Kushner; D A Agard; G L Greene; T S Scanlan; A K Shiau; R M Uht; P Webb
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

2.  Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells.

Authors:  S L Leng; K S Leeding; R H Whitehead; L A Bach
Journal:  Mol Cell Endocrinol       Date:  2001-03-28       Impact factor: 4.102

3.  Accessory elements, flanking DNA sequence, and promoter context play key roles in determining the efficacy of insulin and phorbol ester signaling through the malic enzyme and collagenase-1 AP-1 motifs.

Authors:  Julio E Ayala; Ryan S Streeper; Christina A Svitek; Joshua K Goldman; James K Oeser; Richard M O'Brien
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

Review 4.  Insulin-regulated gene expression.

Authors:  R M O'Brien; R S Streeper; J E Ayala; B T Stadelmaier; L A Hornbuckle
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

5.  Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.

Authors:  S Maruyama; N Fujimoto; K Asano; A Ito
Journal:  J Steroid Biochem Mol Biol       Date:  2001-08       Impact factor: 4.292

Review 6.  Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.

Authors:  A Grimberg; P Cohen
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.

Authors:  Harris Perlman; Kathleen Bradley; Hongtao Liu; Shawn Cole; Eli Shamiyeh; Roy C Smith; Kenneth Walsh; Stefano Fiore; Alisa E Koch; Gary S Firestein; G Kenneth Haines; Richard M Pope
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

8.  Matrix metalloproteinase induction by relaxin causes cartilage matrix degradation in target synovial joints.

Authors:  Sunil Kapila; Wei Wang; Karen Uston
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

Review 9.  IGF-binding protein-4: biochemical characteristics and functional consequences.

Authors:  R Zhou; D Diehl; A Hoeflich; H Lahm; E Wolf
Journal:  J Endocrinol       Date:  2003-08       Impact factor: 4.286

Review 10.  JNK: a new therapeutic target for diabetes.

Authors:  Brydon L Bennett; Yoshitaka Satoh; Alan J Lewis
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

View more
  9 in total

Review 1.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

2.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

3.  Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways.

Authors:  Nisar Ahmad; Wei Wang; Remi Nair; Sunil Kapila
Journal:  Mol Cell Endocrinol       Date:  2012-07-24       Impact factor: 4.102

Review 4.  Emerging roles for LPP in metastatic cancer progression.

Authors:  Elaine Ngan; Alex Kiepas; Claire M Brown; Peter M Siegel
Journal:  J Cell Commun Signal       Date:  2017-10-13       Impact factor: 5.782

5.  NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

Authors:  Anthony G Clementz; Allison Rogowski; Kinnari Pandya; Lucio Miele; Clodia Osipo
Journal:  Breast Cancer Res       Date:  2011-06-14       Impact factor: 6.466

6.  14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage.

Authors:  Walter P Maksymowych; Désirée van der Heijde; Cornelia F Allaart; Robert Landewé; Gilles Boire; Paul P Tak; Yuan Gui; Aziz Ghahary; Ruhangiz Kilani; Anthony Marotta
Journal:  Arthritis Res Ther       Date:  2014-04-21       Impact factor: 5.156

7.  Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis.

Authors:  Zhong-Yu Yuan; Ting Dai; Shu-Sen Wang; Rou-Jun Peng; Xing-Hua Li; Tao Qin; Li-Bing Song; Xi Wang
Journal:  Onco Targets Ther       Date:  2014-09-26       Impact factor: 4.147

8.  Matrix metalloproteinase-1 induction by diethyldithiocarbamate is regulated via Akt and ERK/miR222/ETS-1 pathways in hepatic stellate cells.

Authors:  Tianhui Liu; Ping Wang; Min Cong; Dong Zhang; Lin Liu; Hongyi Li; Qingling Zhai; Zhuo Li; Jidong Jia; Hong You
Journal:  Biosci Rep       Date:  2016-08-24       Impact factor: 3.840

9.  Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.

Authors:  Zaohua Huang; Courtney Myhr; Ross A D Bathgate; Brian A Ho; Amaya Bueno; Xin Hu; Jingbo Xiao; Noel Southall; Elena Barnaeva; Irina U Agoulnik; Juan J Marugan; Marc Ferrer; Alexander I Agoulnik
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.